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Abstract
Primary lymphoma is an uncommon malignancy of the thyroid, comprising of 0.6 to 5 per cent of
thyroid cancers in most series. Primary thyroid lymphomas (PTL) occur most commonly in elderly
women and are commonly of B- cell origin. These frequently present in clinical stage IE and IIE. We
report here ten cases of PTL diagnosed over a period of about 7 years in our institute. Out of these
ten cases, nine were diagnosed on fine needle aspiration cytology (FNAC) and one case was
misdiagnosed as lymphocytic thyroiditis. This case was diagnosed as Non- Hodgkin's lymphoma on
surgical specimen. Five patients are disease free and doing well, while two died of disease and the
other two were lost to follow-up. One patient is currently on chemotherapy. The salient clinical,
biochemical, radiological features, FNA findings along with diagnostic difficulties are discussed.
Introduction
Primary thyroid lymphoma is a rare disease that continues
to produce diagnostic and therapeutic dilemmas. Most
thyroid lymphomas are of B-cell origin [1]. There appear
to be two distinct clinical and prognostic groups of these
rare tumors. The more common subtype, comprising of
up to 70% of cases, is a diffuse large B-cell lymphoma [1].
This subtype appears to have the most aggressive clinical
course with almost 60% of these tumors diagnosed with
disseminated disease. The other subtype is mucosa-associ-
ated lymphoid tissue (MALT) lymphomas comprising of
approximately 6% to 27% of thyroid lymphomas [1].
These have a relatively indolent course. These occur more
commonly in females with female to male ratio of 2–4:1.
The majority of these patients have underlying Hashim-
oto's thyroiditis, which increases the risk for thyroid lym-
phoma by 50 times [2]. The importance of recognizing
primary thyroid lymphoma lies in the fact that this disease
is quite curable without the need for extensive surgery if
recognized early and treated appropriately. In this report,
we discuss FNA findings of ten such patients.
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Materials and methods
Ten cases of primary thyroid non-Hodgkin's lymphoma
(PTL) were retrieved from files of department of Cytopa-
thology, Postgraduate Institute of Medical Education and
Research, Chandigarh, India over a seven year period (Jan
1998- Oct 2004), during this period about 4500 patients
were aspirated for thyroid enlargement. Clinical informa-
tion including age, sex, presenting symptoms, treatment
and subsequent course were recorded. FNAC was per-
formed with 23 G needle and on an average 2–3 passes
were taken to obtain adequate material for diagnosis. His-
topathology of the surgically resected specimens was
available in three cases. Immunocytochemistry (ICC) was
performed for leukocyte common antigen (LCA), cytoker-
atin, CD 20 and CD3 in six cases.
Results
Of the 10 cases, 5 were female and 5 were males with
female to male ratio of 1: 1. The age ranged from 10–61
years with a mean age of 39.6 years. Two patients were less
than 15 years of age. Duration of follow-up ranged from
1 month to 4.3 years. A summary of clinical information
and cytological findings is shown in Table 1. All patients
presented with thyroid enlargement of variable duration
(20 days to 2 years). Seven patients presented with a dif-
fuse goiter, two patients had a multinodular goiter and
only one patient presented as a solitary thyroid nodule.
Other signs and symptoms included stridor, hoarseness,
dyspnoea, dysphagia and sense of heaviness in the neck.
Four patients had associated cervical lymphadenopathy
and three of them had lymphomatous involvement while
one had reactive hyperplasia.
Imaging modalities and bone marrow examination did
not reveal other areas of involvement. CT scan done in
these cases revealed a lesion primarily involving the thy-
roid gland (Figure 1). Hematological parameters, serum
biochemistry and thyroid function tests were normal at
presentation except in three patients, who were hypothy-
roid. Thyroid microsomal antibody (TMA) titer was sig-
nificantly increased (1:80) in six patients.
Cytologically in nine cases, a diagnosis of non- Hodgkin's
lymphoma (NHL) was offered on FNAC. These included
six cases of high grade NHL and three cases of intermedi-
ate grade NHL. The smears in high grade NHL cases were
cellular and comprised of monomorphic population of
large atypical lymphoid cells. These cells were 2–3 times
the size of a mature lymphocyte with opened up chroma-
tin and conspicuous 1–2 nucleoli (Figure 2). In the back-
ground many lymphoglandular bodies were seen. One of
these six cases had subsequent histological confirmation.
In three cases, FNAC smears showed a dual population of
lymphoid cells comprising of an admixture of mature
lymphocytes and larger lymphoid cells. These large lym-
phoid cells were 2–3 times the size of a mature lym-
phocyte and had opened up chromatin and conspicuous
nucleoli (Figure 3). Many monocytoid cells were also
seen. A diagnosis of florid lymphocytic thyroiditis was
Table 1: showing clinical presentation, biochemical investigations and follow- up of ten cases of primary thyroid lymphoma.
No Age/ Sex Clinical Presentation Biochemistry Anti 
thyroid antibody
Diagnosis Follow- up Prognosis
1 61 F Nodular goiter- 2 months Hypothyroid TMA + NHL – HG 3 yrs Disease free
2 48 F Diffuse goiter- 20 months Hypothyroid TMA + FNA- LT Surgery- NHL Lost to follow- up
3 44 M Diffuse goiter- 24 months Euthyroid TMA + NHL – IG 4.3 years Disease free
4 60 F Diffuse goiter- 1 month, local 
lymph nodes
Euthyroid TMA + NHL – IG 4 years Local nodal recurrence 
after 1 1/2 years- RT 
given, Stable.
5 13 M Diffuse goiter- 6 months Euthyroid TMA + NHL – HG 3 years Disease free
6 10 M Diffuse goiter, stridor- 2 
months, local lymph nodes
Euthyroid TMA -ve NHL – HG 6 months Lost to follow- up, Came 
after 6 months with SVC 
syndrome, Died.
7 60 M Solitary nodule- 12 months Hypothyroid TMA + NHL – IG 6 months Disease free
8 20 M Diffuse goiter, Hoarse voice, 
stridor- 6 months, local 
lymph nodes
Euthyroid TMA -ve NHL – HG 1 year Died of disseminated 
disease
9 32 F Nodular goiter, local lymph 
nodes- 5 months
Euthyroid TMA -ve NHL – HG 1 month On treatment- 
chemotherapy
10 48 F Diffuse goiter, stridor- 20 
days
Euthyroid TMA -ve NHL – HG Lost to follow- upCytoJournal 2005, 2:21 http://www.cytojournal.com/content/2/1/21
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considered less likely, because, in thyroiditis, a reactive
population of lymphoid cells of variable sizes admixed
with plasma cells and tingible body macrophages is usu-
ally present. Hence, in these three cases, combining the
clinical presentation and cytological findings, a diagnosis
of NHL – intermediate grade was suggested.
In one case, the diagnosis of lymphoma was missed on
FNA. The patient presented with a diffuse rather than a
nodular swelling and cytology revealed a polymorphic
infiltrate consistent with a reactive hyperplasia which was
seen to infiltrate the follicular epithelial cell clusters.
Hence a diagnosis of lymphocytic thyroiditis was offered.
A subtotal thyroidectomy was performed because of asso-
ciated pressure symptoms. Histopathology revealed a
Non- Hodgkin's lymphoma morphologically and immu-
nohistochemically consistent with a marginal zone B cell
lymphoma.
In six cases, immunocytochemistry (ICC) was performed
on the fine needle aspirate and all cases were CD 20 posi-
tive and CD3 negative.
In all the cases, protocol staging as per the ANN Arbor
staging of NHL was performed. Bone marrow examina-
tion, whole body 67Gallium scan, CECT abdomen and
chest and CSF for malignant cytology was done in all
patients before labeling a case as primary thyroid lym-
phoma. In the present series, 7 cases were of stage I (E)
and three cases were of stage II (E). Lactate dehydrogenase
(LDH) levels were done in six out of ten patients and the
mean LDH level was 628 U/L.
Follow- up information
All the patients received combination chemotherapy
(CHOP regime) with local radiotherapy. Five patients are
alive and are free of disease till date, whereas, two patients
died of the disease. These two patients had high grade
lymphoma and succumbed to disseminated disease. Two
were lost to follow-up and one patient is currently on
chemotherapy.
Discussion
Primary thyroid lymphoma (PTL) is defined as a lympho-
matous process involving the thyroid gland without con-
tiguous spread or distant metastases from other areas of
involvement at diagnosis [3]. PTL constitutes 5% of all
thyroid malignancies and occurs in less than 1% of all
non- Hodgkin's lymphomas [3]. The majority of patients
are middle to old aged women [4]. Studies have shown
that PTL typically arises in the setting of autoimmune thy-
roiditis and it takes, on an average, 20 to 30 years to
develop after the onset of lymphocytic thyroiditis [5]. A
short history of a rapidly enlarging neck mass often asso-
ciated with dyspnoea, difficulty in swallowing, or voice
change is the hallmark presentation of thyroid lymphoma
[6]. Therefore, clinically this may be confused with ana-
plastic thyroid carcinoma. Hoarseness, respiratory dis-
tress, cough and dysphagia were the usual presenting
manifestations in our patients.
Hypothyroidism at the time of diagnosis is documented
in 30–40% of patients due to replacement of thyroid
parenchyma by the lymphomatous process or due to
underlying Hashimoto's thyroiditis. Thyrotoxicosis is
exceedingly rare [7]. Seven of our patients at presentation
were euthyroid and three were hypothyroid. Circulating
antibodies to thyroid peroxidase are positive in 60–80%
of patients suggesting underlying lymphocytic thyroiditis
as a predisposing factor. In the present series, six patients
had significantly elevated thyroid microsomal antibody
titer.
Fine needle aspiration has become the procedure of
choice for the initial pathological diagnosis of thyroid
nodule. However, studies have also shown inconsistent
results in the diagnosis of lymphoma of the thyroid. In
one series, a correct diagnosis with FNAC was made in
70–80% of patients with thyroid lymphoma [8], but in
others, FNA was suggestive but not diagnostic in only 50–
60% of patients [9-12]. In the present study, nine out of
ten cases (90%) of the cases of PTL were correctly diag-
nosed by FNA. A primary thyroid non-Hodgkin lym-
phoma is usually of large cell type [13] and a diagnosis of
CECT scan showing a homogenous isodense soft tissue mass  (3.2 × 4.5 cm) in the region of left lobe of thyroid Figure 1
CECT scan showing a homogenous isodense soft tissue mass 
(3.2 × 4.5 cm) in the region of left lobe of thyroid.CytoJournal 2005, 2:21 http://www.cytojournal.com/content/2/1/21
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large cell lymphoma is easy on FNA and features like lack
of cellular cohesion and presence of lymphoglandular
bodies in the background are features strongly against a
diagnosis of anaplastic carcinoma [14]. ICC confirms the
lymphoid origin of the cells and their B or T- lineage. By
contrast, cytological diagnosis of MALT- lymphomas is
difficult, because of heterogeneous appearance of the neo-
plastic infiltrate [14]. The principal problem with a cyto-
logical diagnosis of low- grade lymphoma of the thyroid
is its differentiation from HT. The distinguishing features
may be the abundance of lymphoid tissue and a high pro-
portion of intermediate centrocyte- like cells in low- grade
NHL as compared to HT. False negative results may be due
to sampling error also as low- grade B- cell MALT lym-
phoma originates from HT and the two usually coexist
[14]. Due attention to dual population of lymphoid cells,
presence of monocytoid cells in FNA smears and extensive
follicular epithelial destruction and the clinical setting
enabled us to diagnose three cases of non- Hodgkin's lym-
phoma of intermediate grade. However, we missed the
diagnosis of NHL on FNAC in one case reported as lym-
phocytic thyroiditis, which on subsequent subtotal thy-
roidectomy, was reported as non- Hodgkin's lymphoma.
FNAC cytomorphology in conjunction with flow cytomet-
ric (FC) immunophenotyping has become a reliable and
accurate method for the diagnosis and classification of
many lymphoproliferative disorders. CD4/CD8 T-cell
ratio comparisons are made with cytomorphological diag-
noses of reactive, atypical, non-Hodgkin lymphoma, and
Hodgkin lymphoma cases [15,16].
PTL frequently present in clinical stage IE and IIE. Treat-
ment is similar to other nodal lymphoma. For patients
with intermediate or high-grade lymphoma, the best
results are obtained from cyclophosphamide, daunoru-
bicin, vincrstine and prednisolone (CHOP) based chemo-
therapy. Radiation therapy is used most commonly after
3–6 courses of chemotherapy in form of modified mantle
irradiation including thyroid, bilateral neck, supraclavicu-
lar area and mediastinum [17]. Our patients received
CHOP based chemotherapy, two of our patients had
relapsed with bone marrow involvement and local nodal
recurrence. One died of lymphomatous process and other
was controlled with radiotherapy. The poor prognostic
factors include age more than 60 years, performance sta-
tus grater than 1, elevated lactate dehydrogenase (LDH)
and β2 microglobulin, extranodal sites more than 1 and
Ann -Arbor staged III-IV [18,19].
In summary, we report a retrospective study of ten cases of
primary thyroid lymphomas. The diagnosis was estab-
lished by fine needle aspiration in nine cases and one case
was misdiagnosed as lymphocytic thyroiditis, which was
diagnosed on surgical specimen. The cytological diagnosis
of high grade lymphoma is easy and ICC can confirm sus-
picious cases. The diagnosis of low grade lymphoma is
more difficult but clinical and radiological suspicion and
cytomorphological features can help reaching the correct
diagnosis in such cases.
Abbreviations
NHL – Non- Hodgkin's lymphoma
HG- High grade
IG- Intermediate grade
Aspiration smear showing a typical dual population of lym- phoid cells in a case of intermediate grade non- Hodgkin's  lymphoma (H&E × 512) Figure 3
Aspiration smear showing a typical dual population of lym-
phoid cells in a case of intermediate grade non- Hodgkin's 
lymphoma (H&E × 512).
Aspiration smear showing monomorphic population of atypi- cal lymphoid cells in a case of high grade non- Hodgkin's lym- phoma (MGG × 512) Figure 2
Aspiration smear showing monomorphic population of atypi-
cal lymphoid cells in a case of high grade non- Hodgkin's lym-
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TMA- Thyroid microsomal antibody
HT- Hashimoto's thyroiditis
LT- Lymphocytic thyroiditis
RT- Radiotherapy
SVC- Superior vena cava.
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